“Despite the controversy caused by the protestor’s appearance, his presence did seem to attract a larger crowd, and [one of the organizers] said that his arrival was a good thing. ‘I was going to let him stay as long as he wanted to, because once white people see how [a racist] acts, they can just reflect on that and see, ‘Oh, I’m not like that. Oh, I actually might want to help.’ And they might want to push against what his thoughts and what his beliefs are.” - A racist clown rolls through a small Black Lives Matter rally at East Tennessee State University, and because of the inherent drama of a person with a Conf...
Thursday, June 14, 2007
BLOGSCAN - Pfizer Trumpets Good News About Lipitor, Whispers Bad News
On both Pharmalot and the Wall Street Journal Health Blog are posts about how Pfizer Inc., the world's largest drug company, trumpeted the 14% superiority of its cholesterol lowering drug Lipitor (atorvastatin) over generic simvastatin based on an observational study, then recently very quietly filed a statement with the US Securities and Exchange Commission (SEC) of all places noting that the original findings were incorrect, and that Lipitor did not show a statistically significant advantage over simvastatin.